PROCEPT BioRobotics Quarterly Balance Sheet
NASDAQ: PRCTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
PROCEPT BioRobotics financial position
As of Jun 30, 2026, PROCEPT BioRobotics reported total assets of $479.4 million, down 6.6% from a year earlier against total liabilities of $139.3 million. Shareholders' equity stood at $340.1 million, or 70.9% of assets. The company held $227.9 million in cash and equivalents against $51.7 million of debt, a net cash position of $176.2 million.
The current ratio (current assets divided by current liabilities) was 6.55, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.15.
Summary generated from market data by MetaCap's automated system. Methodology
PROCEPT BioRobotics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 227.91M | 245.64M | 286.50M | 294.28M | 302.72M | 316.21M | 333.73M | 196.76M | 214.09M | 225.58M | 257.22M | 287.09M |
| Receivables | 107.61M | 96.39M | 83.53M | 84.50M | 80.82M | 79.27M | 83.50M | 69.05M | 58.92M | 56.08M | 48.38M | 34.62M |
| Inventory | 77.06M | 77.54M | 70.69M | 66.72M | 67.03M | 62.33M | 56.17M | 50.85M | 43.87M | 41.62M | 39.76M | 42.20M |
| Total Current Assets | 420.29M | 428.03M | 450.38M | 454.75M | 458.07M | 465.79M | 481.84M | 322.98M | 321.89M | 329.19M | 350.57M | 368.67M |
| Property, Plant & Equipment | 31.83M | 31.74M | 30.40M | 30.02M | 28.60M | 28.13M | 26.71M | 26.61M | 27.68M | 28.49M | 28.75M | 27.03M |
| Total Assets | 479.35M | 487.06M | 508.08M | 511.54M | 513.05M | 519.38M | 534.02M | 374.14M | 374.35M | 382.90M | 404.72M | 421.13M |
| Accounts Payable | 15.07M | 18.85M | 17.29M | 11.12M | 11.78M | 14.83M | 10.03M | 15.09M | 9.95M | 10.08M | 13.50M | 13.60M |
| Short-Term Debt | — | — | — | — | — | — | — | 0 | 0 | 0 | — | 0 |
| Total Current Liabilities | 64.20M | 63.64M | 65.80M | 53.90M | 49.73M | 52.06M | 53.13M | 53.65M | 42.84M | 38.65M | 45.93M | 41.36M |
| Long-Term Debt | 51.72M | 51.66M | 51.62M | 51.57M | 51.52M | 51.50M | 51.47M | 51.44M | 51.40M | 51.37M | 51.34M | 51.31M |
| Total Liabilities | 139.28M | 139.40M | 142.21M | 131.26M | 127.26M | 130.22M | 131.80M | 132.92M | 122.57M | 118.85M | 123.97M | 121.77M |
| Shareholders' Equity | 340.07M | 347.67M | 365.87M | 380.28M | 385.80M | 389.16M | 402.22M | 241.22M | 251.78M | 264.05M | 280.75M | 299.36M |
| Retained Earnings | -700.06M | -673.20M | -641.56M | -611.71M | -590.30M | -570.72M | -545.99M | -527.13M | -506.15M | -480.53M | -454.57M | -427.07M |
| Total Debt | 51.72M | 51.66M | 51.62M | 51.57M | 51.52M | 51.50M | 51.47M | 51.44M | 51.40M | 51.37M | 51.34M | 51.31M |
| Net Cash (Debt) | 176.20M | 193.98M | 234.89M | 242.72M | 251.19M | 264.71M | 282.25M | 145.32M | 162.69M | 174.21M | 205.88M | 235.78M |
| Shares Outstanding | 57.25M | 56.90M | 56.32M | 55.87M | 55.58M | 55.28M | 54.72M | 52.15M | 51.90M | 51.39M | 50.77M | 50.47M |
This table shows 12 quarterly periods of PROCEPT BioRobotics's balance sheet, from Q2 2026 back to Q3 2023, across 16 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow PRCT's reporting calendar. What is a balance sheet?